France : Press Release: Dupixent (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old

Press/Media

Period	17 Oct 2022

Media coverage

Title	France : Press Release: Dupixent (dupilumab) late-breaking Phase 3 data presented at UEG Week 2022 showed significant histological remission of eosinophilic esophagitis (EoE) in children 1 to 11 years old
Media name/outlet	Tendernews.com
Country/Territory	India
Date	17/10/22
URL	metabase.moreover.com/noarticleurl?type=psh&lni=66PH-G231-JBYT-H151-00000-00
Persons	Mirna Chehade